Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “DECUBITUS”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 829 records · Page 46Linked to original sources

[The use of skin-muscle flaps in decubitus ulcer treatment].

For the period 1981 up to 1987 25 patients with a total of 27 decubital ulcers have been healed successfully in the II. Clinic of Surgery, Med. Faculty in Pazardzhik, and the University Clinic of Burns in Sofia. The application of myocutaneous flaps versus free skin grafts plus ulcer first covering after excision appears to have definite advantage in the treatment of such patients.

Adolescent↗

[Treatment of decubitus ulcer with Crilanomer and dextranomer].

In a clinical study on decubital ulcers, 95 patients in 10 hospitals were treated with dextranomer and crilanomer. The size of the ulcer surface and the physician's evaluation of the healing status at the end of treatment served as the most important criteria for our assessment of the curative effect. Both preparations proved equivalent in the statistical test. Crilanomer revealed slightly better results than dextranomer with regard to the physician's overall evaluation al well as odor, exudation, and cleansing. Both modes of treatment were accompanied by local incompatibility reactions of a minor degree; there were no systemic side effects in either preparation.

Acrylonitrile↗

[The organization of a working group for the prevention of decubitus lesions].

The authors report the results of a two years monitoring program focused on patients at risk of and with bedsores in the general hospital of Castelfranco Veneto. The purpose of the multidisciplinary exercise (which saw the participation of nurses, pharmacists, doctors) was the activation and the evaluation of treatment protocols. The overall recruited sample included 679 patients, with a prevalence of 61% of lesions at the occasion of the first observation, and of 57% in the last one. The hardly quantitatively different prevalence is better understood from a qualitative point of view: the number of lesions per patients drops slightly from 1.9 to 1.7; one out of four of the "at risk" patients became "at no risk"; a 30% improvement is observed with respect to treatment efficacy. It is suggested that a positive effect may be obtained through a sustained attention to the problem and the careful definition of the interventions to be planned.

Humans↗